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ABSTRACT: Enantioselective desymmetrization of Cs-symmetric (h5-2,5-dialkenylphospholyl)(allyldiphenylphosphine)manganese(I) 
dicarbonyl complexes 1 was realized by the molybdenum-catalyzed asymmetric ring-closing metathesis (ARCM), and the corresponding 
bridged planar-chiral phosphacymantrene derivatives 2 were obtained in good yields with excellent enantioselectivity. The enantioselectivity 
of the ARCM reaction was strongly influenced by the structures of the phospholyl-bound alkenyl groups, and the highest enantioselectivity of 
up to 99% ee was achieved in the reaction of 1d and 1e, which possess the 2-methylpropenyl substituents at the 2- and 5-positions of the h5-
phospholides. Single-enantiomeric planar-chiral 2d, which was obtained by the recrystallization of the highly enantiomerically enriched 
ARCM product, can serve as a chiral ligand for the palladium-catalyzed asymmetric allylic alkylation to show good enantioselectivity in up to 
74 % ee. 
INTRODUCTION 
Phospholides (phospholyl anions; phosphacyclopentadienyl an-
ions) are unique ligands in organometallic chemistry,1 which pri-
marily coordinate to a transition-metal cation in an h5-fashion as 
six-electron donors to form the corresponding phosphametallo-
cenes.2 Whereas the phosphorus atom in a phosphametallocene 
still possesses a lone-pair on it, a phosphametallocene is capable of 
ligating to a second transition-metal as a phosphine-like two-
electron donor. Unsymmetrical introduction of proper substituents 
onto a phospholide core makes the two faces of a planar phospholyl 
anion enantiotopic to each other. And thus, the h5-coordination of 
an unsymmetric phospholide to a metal cation, which discriminates 
the two enantiotopic faces, induces "planar chirality" in the phos-
phametallocene species (Scheme 1).3 
Scheme 1. Coordination Chemistry of Phospholides 
Since the initial discovery of phosphacyman-
trenes4/phosphaferrocenes5 in the late 1970s, various planar-chiral 
phosphametallocenes have been prepared.6 However, they were 
obtained in racemic forms and the enantiomeric resolution was not 
reported until the Ganter's first achievement in 1997.7 Since then, 
various planar-chiral and "single-enantiomeric" phosphaferrocenes 
have been prepared and utilized as useful chiral ligands in metal-
catalyzed asymmetric reactions.3 Up until now, all the studies on 
the planar-chiral and scalemic phosphametallocenes are about 
iron(II) species (phosphaferrocenes), and the investigations on 
planar-chiral phosphacymantrenes have been virtually unexplored. 
It should be mentioned that the most optically active planar-chiral 
phosphaferrocenes were obtained by any one of the following; the 
enantiomeric resolution of the preformed racemates, the derivatiza-
tion of the resolved precursors, or the diastereoselective separation 
utilizing chiral side-arms on the phosphaferrocene cores. 
In the last few decades, we have been interested in modulating 
transition-metal complexes by the ring-closing metathesis (RCM) 
reaction.8-10 The RCM strategies have been successfully extended to 
the enantioselective counterparts by using the Schrock-Hoveyda 
chiral molybdenum-alkylidene catalysts,11 and various planar-chiral 
transition metal complexes have been prepared in excellent enanti-
oselectivity either by the kinetic resolution of the racemic sub-
strates12 or by the desymmetrization of the Cs-symmetric precur-
sors13 (Scheme 2). These are the examples of catalytic asymmetric 
synthesis of planar-chiral transition-metal complexes, which is a 
research area rapidly developing recently.14,15 The asymmetric ring-
closing metathesis (ARCM) protocol was applicable to the 
desymmetrization of prochiral phosphaferrocenes and the corre-
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 sponding planar-chiral species were obtained in up to 99% ee 
(Scheme 2, (b)).13a 
In this article, we would like to report the catalytic asymmetric 
synthesis of planar-chiral phosphacymantrene derivatives by the 
ARCM method. The Cs-symmetric substrate (see Figure 1) for this 
study possess an allylphosphine ligand and an h5-2,5-
bis(alkenyl)phospholide, where the two alkenyl substituents in the 
phospholide are identical and enantiotopic to each other. The mo-
lybdenum-catalyzed ARCM reaction between the two ligands takes 
place smoothly to desymmetrize the prochiral substrates, and the 
bridged planar-chiral products are obtained in high yields with 
excellent enantioselectivity of up to 99% ee. The simple recrystalli-
zation of the enantiomerically enriched planar-chiral ARCM prod-
uct provided the enantiomerically pure phosphacymantrene spe-
cies, which was applied to the palladium-catalyzed asymmetric 
allylic alkylation (the asymmetric Tsuji-Trost reaction)16 as a chiral 
ligand to show the good enantioselectivity in up to 74% ee. It 
should be noted that, to the best of our knowledge, this work is the 
first example of preparing planar-chiral phosphacymantrenes in 
optically active forms. 
Scheme 2. Enantioselective Synthesis of Planar-Chiral Transi-
tion-Metal Complexes by Asymmetric Ring-Closing Metathe-
sis 
 
RESULTS AND DISCUSSION 
Design and Preparation of Cs-Symmetric (h5-
Phospholyl)manganese Substrates 1 for ARCM Desymmetri-
zation. The substrates used in this study are (h5-2,5-
dialkenylphospholyl)(allyldiphenylphosphine)manganese(I) di-
carbonyl (1), where the two alkenyl substituents at the 2- and 5-
positions of the h5-phospholyl ligand are identical. While the allyl 
group in the coordinating phosphine is a monosubstituted olefin, 
the two alkenyl groups in the h5-phospholyl ligand are polysubsti-
tuted ones except for those in 1b, which was designed and prepared 
for the control experiment (Figure 1). 
 
Figure 1. Structures of Cs-symmetric (h5-phospholyl)manganese sub-
strates 1a-e. 
The design concept of the substrates is explained in Scheme 3 for 
the ARCM reaction of 1a. In general, less substituted olefins are 
more reactive than more substituted ones in olefin metathesis. And 
thus, the reaction pathway would be effectively regulated in the 
ARCM reaction of 1a as explained below. The first step in the 
ARCM reaction between a chiral molybdenum-alkylidene precata-
lyst and 1a might take place at the least substituted olefin in 1a, that 
is the phosphorus-bound allyl group, to form intermediate A. Sub-
sequently, the ring-closure in A proceeds intramolecularly to pro-
vide bridged product 2a. The enantioselectivity of the ARCM pro-
cess is determined in the second step, and the intramolecular na-
ture of this step would effectively discriminate the two diastereo-
topic (not enantiotopic with the stereogenic Mo* moiety) phos-
pholyl-bound alkenyl groups in A leading to the higher enantiose-
lectivity in the ARCM reaction. Another possible reaction pathway 
is via intermediate B, and the enantiodetermining step in the latter 
pathway is the formation of B. Whereas the reaction between the 
chiral molybdenum-alkylidene species and 1a giving B is an inter-
molecular process, the lesser enantiocontrol is presumed by this 
route. Consequently, the exclusion of the reaction pathway via B 
might be crucial for achieving high enantioselectivity in the present 
ARCM reaction. With the phospholyl-bound polysubstituted 
alkenyl groups in 1a,c-e, the formation of intermediate B is less 
likely in the ARCM of 1a,c-e. However, the two reaction pathways 
may compete in the ARCM of 1b, and thus the lesser enantioselec-
tivity is expected for the reaction. 
Scheme 3. Presumed ARCM Reaction Pathways from 1a to 2a 
 
(b) Desymmetrization of Cs-Symmetric Complexes13a
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 Cs-symmetric substrates 1a-c, which have the allylic substituents 
at the 2- and 5-positions of the h5-phospholide ligands, were pre-
pared as outlined in Scheme 4. The conversion of 3 to 7 was carried 
out without isolating reactive synthetic intermediates 4-6 (see Ex-
perimental Section for detail). Treatment of 1,13-dien-4,10-diyne 3 
with Cp2ZrCl2 in the presence of activated magnesium generated 
zirconacyclopentadiene 4. The metallacycle transfer reaction of 4 
with phosphorus trichloride afforded P-chlorophosphole 5.17 Sub-
sequently, the reaction with lithium metal provided lithium phos-
pholide 6 in situ, which was reacted with BrMn(CO)5 to give phos-
phacymantrene 7 as a yellow oil. The photo-induced carbonyl-
phosphine exchange reaction furnished 1 as a yellow crystalline 
solid. 
On the other hand, substrates 1d,e were prepared by a different 
method (Scheme 5). The 2-methylpropenyl substituents were 
introduced at the a-positions of the phospholide cores in 10 and 
12 by the thermal [1,5]sigmatropic shift of the phosphorus-bound 
methallyl substituents in 9/11,18 which took place with a methallyl-
to-(2-methylpropenyl) rearrangement. Subsequently, 2,5-bis(2-
methylpropenyl)phospholides 12d,e thus obtained were converted 
to the corresponding phosphacymantrene derivatives 7 and 1 by 
the standard methods. In the synthetic sequence shown in Scheme 
5, reactive intermediates 9-12 were not isolated, and the reaction 
progress was monitored by the 31P-NMR in the protio-solvents (i.e., 
the reaction solvents. See Experimental Section for detail). It 
should be noted that phospholides having vinylic substituents at 
the 2- and 5-positions (such as 12d,e) could not be prepared by the 
zirconacycle-mediated method as in Scheme 4. The reactions be-
tween Cp2ZrCl2/Mg and 1,11-dien-3,9-diynes gave complex mix-
tures and the desired 2,5-divinylzirconacyclopentadienes could not 
be obtained because the conjugated enyne moieties in 1,11-dien-
3,9-diynes might react with the Zr(II) species in the different man-
ners.19 
Scheme 4. Preparation of Cs-Symmetric Phosphacymantrene Substrates 1a-c 
 
Scheme 5. Preparation of Cs-Symmetric Phosphacymantrene Substrates 1d,e 
 
Enantioselective Desymmetrization of Cs-Symmetric 1 by 
Molybdenum-Catalyzed Asymmetric Ring-Closing Metathesis 
(ARCM). The prepared substrates were subjected to the desym-
metrization studies with various chiral molybdenum-alkylidene 
precatalysts, and the results are summarized in Table 1. Screening 
of the chiral precatalysts was examined using 1a as a prototypical 
substrate. The reactions were carried out in benzene at 23 °C in the 
presence of an appropriate chiral molybdenum-alkylidene precata-
lyst (10 mol %), that was generated in situ from the molybdenum 
precursor, (pyrrolyl)2Mo(=CHCMe2Ph)(=N-C6H3-2,6-iPr2), and 
an axially chiral biphenol derivative.20 Under these conditions, the 
Mo-precatalyst generated with (R)-L121a showed insufficient cata-
lytic activity with poor enantioselectivity giving RCM product (–)-
2a in 87% conversion and 31% ee (Table 1, entry 1). The molyb-
denum precatalyst coordinated with (R)-L221b showed complete 
conversion of 1a under otherwise identical conditions with excel-
lent enantioselectivity giving (–)-2a in 91% ee (entry 2). On the 
other hand, Mo/(R)-L3,21c which was the best catalyst in the kinet-
ic resolution of planar-chiral bromocymantrene derivatives,12e was 
inappropriate for the desymmetrization reaction affording (–)-2a 
in 98% conversion with 61% ee (entry 3). The Mo precatalyst pre-
pared with (R)-L4,21d which was the most effective catalyst in the 
desymmetrization of Cs-symmetric phosphaferrocenes,13a also 
showed reasonable performance; (–)-2a was obtained quantitative-
ly in 72% ee (entry 4). 
After the optimization studies, Mo/(R)-L2 and/or Mo/(R)-L4 
were applied to the other substrates. Substrate 1b possesses the two 
THF
Cp2ZrCl2, Mg
• Li+
–
BrMn(CO)5,  Δ Ph2P(allyl), hν
(CH2)4 R'
R
R
R
R
R'
Zr
Cp2
R'R'
R
R
R
R PCl
R'R'
R
R
R
R
PCl3
CH2Cl2
P
R'R'
R
R
R
R
Li
THF Mn
P
Ph2 CO
CO
P
R'
R
R
R
R'
R
1a-c
3a-c 4a-c 5a-c
6a-c 7a-c
Mn
OC CO
CO
P
R'
R
R
R
R'
R
a: R = H, R' = Me
b: R = H, R' = H
c: R = Me, R' = H
Mn
P
Ph2 CO
CO
P
R
R
1d,e7d,e
Mn
OC CO
CO
P
R
R
R R
P
Ph
R R
P
R R
P • K+
R R
P
R R
P
–
• K+
–
1) Li (excess)
2) AlCl3 (1/3 equiv)
3) methallyl-Cl
methallyl-Cl
BrMn(CO)5,  Δ Ph2P(allyl), hν
KOtBu, THF
140 °C (sealed)
KOtBu, THF
140 °C (sealed)
8d,e 9d,e 10d,e 11d,e
12d,ed: R,R = -(CH2)4-e: R,R = Me, Me
 enantiotopic phospholyl-bound allyl substituents in place of the 
methallyl groups in 1a. Because all the three alkenyl substituents in 
1b are monosubstituted olefins, the discrimination between the 
phospholyl-bound allyl groups and the allyl substituent of the 
phosphine ligand was not effective in the ARCM of 1b. As we ex-
pected, indeed, the desymmetrization reaction of 1b by Mo/(R)-
L2 was poorly enantioselective and provided nearly racemic 2b of 
less than 1% ee (entry 5). The results in entries 2 and 5 support the 
validity of the reaction pathways discussed in Scheme 3 (see above). 
It was found that the phospholyl-bound prenyl groups effectively 
differentiated the reactivity among the alkenyl substituents in 1c 
leading to the reasonable enantioselectivity in its ARCM reaction 
(entries 6 and 7). While cyclized product (–)-2c was obtained in 
58% ee quantitatively using Mo/(R)-L2, the reaction by Mo/(R)-
L4 gave (–)-2c in 89% ee. However, the trisubstituted olefin moie-
ty in the prenyl groups somewhat reduced the reactivity of 1c to-
ward the ring-closure, and the conversion of the reaction using 
Mo/(R)-L4 remained in only 27% (entry 7). 
Meanwhile, the substrates with the 2-methylpropenyl (b,b-
dimethylvinyl) groups on the phospholide core showed far better 
enantioselectivity in the present desymmetrization reaction. The 
ARCM reaction of 1d catalyzed by Mo/(R)-L2 proceeded smooth-
ly and the corresponding bridged product (–)-2d was obtained in 
97% ee and >99% yield (entry 8). In the same way, the ARCM 
reaction of 1e provided (–)-2e in >99% yield and in 99% ee in the 
presence of Mo/(R)-L2 (entry 10). The molybdenum-alkylidene 
precatalyst coordinated with (R)-L4 was not effective for the reac-
tions of 1d and 1e affording the ARCM products of low enantiose-
lectivity ranging from 14 to 17 % ee (entries 9 and 11). 
Table 1. Molybdenum-Catalyzed ARCM Desymmetrization of 
Cs-Symmetric Phosphacymantrene 1a-ea 
 
entry substrate chiral L conversion (%)b %eec,d 
1 1a (R)-L1 87 31 (–) 
2 1a (R)-L2 >99 (>99) 91 (–) 
3 1a (R)-L3 98 61 (–) 
4 1a (R)-L4 >99 72 (–) 
5 1b (R)-L2 >99 (77) <1 (n.d.) 
6 1c (R)-L2 >99 (>99) 58 (–) 
7 1c (R)-L4 27 89 (–) 
8 1d (R)-L2 >99 (>99) 97 (R) 
9 1d (R)-L4 98 14 (R) 
10 1e (R)-L2 >99 (>99) 99 (–) 
11 1e (R)-L4 98 17 (–) 
a The reaction was carried out using 1 (35 µmol) in benzene for 12 h 
in the presence of an appropriate molybdenum-alkylidene precatalyst 
that was generated in situ (10 mol %) unless otherwise noted. b Deter-
mined by the 31P-NMR analysis. The numbers in parentheses are the 
isolated yields after purification by silica gel column chromatography. c 
Determined by HPLC on a chiral stationary phase (see Experimental 
Section for details). d Sign of specific rotation or absolute configuration 
of the products in parentheses.  
Determination of Absolute Configuration of (–)-2d. Single 
crystals of the levorotatory enantiomer of 2d ([a]D24 = –91.3 (c = 
2.60, EtOAc) for the sample of 97% ee) suitable for X-ray crystal-
lography were grown from a cold pentane solution as orange prisms. 
The crystal structure of (–)-2d, which is with disorder at the phos-
pholyl-bound tetramethylene moiety, is shown in Figure 2 with the 
selected bond lengths and angles.22 The Flack parameter was de-
termined to be 0.03(2) for the structure, and the absolute configu-
ration of (–)-2d is unambiguously assigned to be (R) (see Support-
ing Information for details). The configurations of the other 
desymmetrization products were deduced by analogy. 
The distance between Mn1 and the h5-phospholyl centroid is 
1.777(4) Å, which is comparable to those in the analogous bridged 
cymantrene derivatives.9g,h The crystal structure shows the distor-
tion in 2d from the ideal three-legged piano-stool structure due to 
the short C3-bridge between the h5-phospholyl and the Mn1-
bound phosphine; while C(carbonyl)-Mn1-phospholyl centroid 
angles are 124.67(8) and 124.58(8), P2-Mn1-phospholyl centroid 
angle is considerably smaller (120.12(9)°). 
 
Figure 2. Ball-and-stick drawing of (R)-(–)-2d with selected atom 
numbering. Selected bond lengths (Å) and angles (deg): P1-C5 = 
1a-e 2a-e
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 1.786(3), P1-C12 = 1.803(3), C5-C6 = 1.415(4), C6-C11 = 1.427(4), 
C11-C12 = 1.401(4), Mn1-P1 = 2.3720(9), Mn1-P2 = 2.2432(8), 
Mn1-C5 = 2.170(3), Mn1-C6 = 2.174(3), Mn1-C11 = 2.196(3), Mn1-
C12 = 2.183(3), Mn1-Phospholyl Centroid = 1.778(4); C5-P1-C12 = 
89.0(1), P2-Mn1-Phospholyl Centroid = 120.12(9), C28-Mn1-
Phospholyl Centroid = 124.67(8), C29-Mn1-Phospholyl Centroid = 
124.58(8). 
Application of Planar-Chiral (R)-(–)-2d to Palladium-
Catalyzed Asymmetric Allylic Alkylation. Recrystallization of 
(R)-2d (97% ee), which was obtained as in Table 1 (entry 8), pro-
vided enantiomerically pure (R)-2d. Potential usefulness of the 
planar-chiral bridged phosphacymantrene derivative was explored 
for the palladium-catalyzed asymmetric allylic alkylation reaction.16 
The palladium complexes generated in situ from [PdCl(p-allyl)]2 
and (R)-2d (Pd/(R)-2d = 1/1) catalyzed the reaction of racemic 
1,3-diphenyl-2-propenyl acetate with dimethyl malonate in the 
presence of BSA to give the alkylation product in 48% ee and in 
99% yield at 23 °C. The enantioselectivity could be improved to 
74% ee at 0 °C, but the reaction was slow at this temperature 
(Scheme 6). Although these results need further improvement, the 
reaction shown in Scheme 6 clearly indicates the potential validity 
of planar-chiral phosphacymantrene derivatives in asymmetric 
synthesis. To the best of our knowledge, this is the first example of 
utilizing a planar-chiral phosphacymantrene as a chiral ligand in 
transition-metal catalysis. 
Scheme 6. Pd-Catalyzed Asymmetric Allylic Alkylation of rac-
1,3-Diphenyl-2-propenyl Acetate 
 
CONCLUSIONS 
In summary, we have developed a highly efficient method for the 
enantioselective desymmetrization of Cs-symmetric (h5-2,5-
dialkenylphospholyl)(allyldiphenylphosphine)manganese(I) di-
carbonyl complexes 1 by the molybdenum-catalyzed asymmetric 
ring-closing metathesis (ARCM). Various bridged planar-chiral 
phosphacymantrene derivatives 2 were prepared in near-
quantitative yields with excellent enantioselectivity of up to 99% ee 
by this method. It was observed that the enantioselectivity of the 
ARCM reaction was strongly influenced by the structure of the 
phospholyl-bound alkenyl groups, and the highest enantioselectivi-
ty of 97-99% ee was achieved in the reaction of 1d and 1e, which 
possess the 2-methylpropenyl substituents at the 2-, and 5-
positions of the h5-phospholides. Recrystallization of the highly 
enantiomerically enriched ARCM product, 2d of 97% ee, gave 
enantiomerically pure 2d, which could serve as a chiral ligand for 
the palladium-catalyzed asymmetric allylic alkylation to show good 
enantioselectivity in up to 74 % ee. 
EXPERIMENTAL SECTION 
General Information. All anaerobic and/or moisture sensi-
tive manipulations were carried out with standard Schlenk tech-
niques under predried nitrogen or with glovebox techniques under 
prepurified argon. 1H NMR (at 400 MHz) and 13C NMR (at 100 
MHz) chemical shifts are reported in ppm downfield of internal 
tetramethylsilane. 31P NMR (at 162 MHz) chemical shifts are ex-
ternally referenced to 85% H3PO4. Tetrahydrofuran and benzene 
were distilled from benzophenone-ketyl under nitrogen prior to use. 
Dichloromethane was distilled from CaH2 under nitrogen prior to 
use. 2,13-Dimethyltetradeca-1,13-dien-4,10-diyne (3a),13a tetrade-
ca-1,13-dien-4,10-diyne (3b),9b 1,2-dimethylenecyclohexane,23 3,4-
dimethyl-1-phenylphosphole (8e),24 (pyrrol-
yl)2Mo(=CHCMe2Ph)(=N-C6H3-2,6-iPr2),18 (R)-3,3'-tBu2-H8-
binaphthol (L1),21a (R)-3,3'-(Ph2CH)2-H8-binaphthol (L2),21b (R)-
3,3'-[3,5-(CF3)2C6H3]2-2,2'-binaphthol (L4)21d were prepared ac-
cording to the reported methods. All the other chemicals were 
obtained from commercial sources and used as received unless 
otherwise noted. 
2,15-Dimethylhexadeca-2,14-dien-5,11-diyne (3c). To a so-
lution of nPrMgBr, prepared from nPrBr (23.5 g, 191 mmol) and 
Mg (4.59 g, 189 mmol) in THF (160 mL), was added 1,7-
octadiyne (8.73 g, 82.2 mmol) dropwise by means of syringe at 
0 °C. After stirring the mixture for 3 h at room temperature, to this 
were added CuCl (3.3 g, 33 mmol) and 4-chloro-2-methyl-2-
butene (23.3 g, 222 mmol) successively, then the mixture was 
stirred at 60 °C for 3 h. The reaction mixture was quenched with 
saturated NH4Cl, then partitioned between hexane and H2O. The 
hexane layer was washed with brine, dried over MgSO4, filtered, 
then evaporated. The GC and NMR analyses of the crude mixture 
showed the presence of ca. 5% of 3,3,14-trimethylpentadeca-1,13-
dien-4,10-diyne, which could be removed by careful vacuum-
distillation. Colorless oil. Yield: 8.38 g (34%). 1H NMR (CDCl3): d 
1.57 (m, 4H), 1.62 (s, 6H), 1.70 (s, 6H), 2.17 (t, J = 2.4 Hz, 4H), 
2.85 (d, J = 6.8 Hz, 4H), 5.18 (tt, J = 7.2 and 1.6 Hz, 2H). 13C{1H} 
NMR (CDCl3): d 17.6, 17.9, 18.4, 25.5, 28.2, 79.1, 79.4, 119.9, 
133.2. EI-HRMS Calcd for C18H26: 242.2035. Found: 242.2025. 
Preparation of (h5-Phospholyl)Mn(I)(CO)3 Derivatives 
(7a-c). A typical procedure is given for the synthesis of 7a. To a 
suspension of Mg (251 mg, 10.3 mmol) in THF (1 mL), which was 
activated with 1,2-dibromoethane (22 µL, 0.26 mmol), was added 
a solution of 3a (2.19 g, 10.2 mmol) and Cp2ZrCl2 (2.94 g, 10.1 
mmol) in THF (30 mL) via cannula at room temperature, and the 
mixture was stirred overnight. The mixture was evaporated to dry-
ness under reduced pressure and the residue was partially dissolved 
in CH2Cl2 (50 ml). To the resulting suspension was added phos-
phorus trichloride (1.8 mL, 21 mmol) at 0 °C, and the mixture was 
stirred at room temperature for 3 h. All the volatiles were removed 
under reduced pressure, then the residue was extracted with hexane 
(30 mL × 3) and the combined hexane extract was filtrated 
through dried Celite. After removing the solvent under reduced 
pressure, P-chlorophosphole 5a thus obtained was treated with 
excess lithium wire (ca. 500 mg, ca. 72 mmol) in THF (20 mL) to 
give a solution of lithium phospholide 6a. In a different flask, 
BrMn(CO)5 (2.50 g, 9.10 mmol) was taken, and to this was added 
the solution of 6a obtained as above at room temperature. The 
resulting mixture was stirred at room temperature for 12 h. The 
mixture was evaporated to dryness under reduced pressure, then 
the residue was dissolved in xylenes (15 mL). The mixture was 
heated to 120 °C and stirred for 12 h. After cooling to room tem-
perature, the mixture was filtered through a pad of Celite, and the 
filtrate was evaporated to dryness under reduced pressure. The 
residue was chromatographed on silica gel (hexane/benzene = 
10/1) under nitrogen to give 7a as a yellow oil. The reaction condi-
tions were not optimized. The characterization data for 7a-c are 
given below. 
Ph Ph
CH(CO2Me)2Ph Ph
OAc
CH2(CO2Me)2
+
[PdCl(π-allyl)]2 (3.6 mol %)
(R)-2d (7.2 mol %)
BSA, KOAc, CH2Cl2
at 23 °C (42 h): 48% ee (99%)
at 0 °C (7 days): 74% ee (54%)
 [h5-3,4-(Butan-1,4-diyl)-2,5-
dimethallylphospholyl]manganese(I) Tricarbonyl (7a). Yellow 
oil. Yield: 1.19 g (34%) from BrMn(CO)5 (2.50 g, 9.10 mmol). 1H 
NMR (C6D6): d 1.25-1.31 (m, 2H), 1.54 (s, 6H), 1.57-1.66 (m, 
2H), 2.08-2.23 (m, 4H), 2.54 (d, J = 11.0 Hz, 4H), 4.61 (br, 2H), 
4.71 (br, 2H). 13C{1H} NMR (C6D6): d 22.4 (s), 22.6 (d, JPC = 2.8 
Hz), 24.1 (s), 36.4 (d, JPC = 17.9 Hz), 110.9 (d, JPC = 60.9 Hz), 
112.1 (d, JPC = 1.6 Hz), 113.9 (d, JPC = 5.7 Hz), 144.2 (d, JPC = 1.3 
Hz), 225.2 (s). 31P{1H} NMR (C6D6): d –23.1 (s). Anal. Calcd for 
C19H22MnO3P: C, 59.38; H, 5.77. Found: C, 59.39; H, 5.79. EI-
HRMS Calcd for C19H22MnO3P: 384.0687. Found: 384.0674. 
[h5-3,4-(Butan-1,4-diyl)-2,5-
diallylphospholyl]manganese(I) Tricarbonyl (7b). Yellow oil. 
Yield: 769 mg (29%) from BrMn(CO)5 (2.05 g, 7.42 mmol). 1H 
NMR (C6D6): d 1.22-1.33 (m, 2H), 1.56-1.64 (m, 2H), 1.92-2.02 
(m, 2H), 2.11-2.20 (m, 2H), 2.48-2.56 (m, 4H), 4.85-4.94 (m, 4H), 
5.56-5.68 (m, 2H). 13C{1H} NMR (C6D6): d 22.4 (s), 24.2 (s), 
32.9 (d, JPC = 17.7 Hz), 111.9 (d, JPC = 60.6 Hz), 113.4 (d, JPC = 5.9 
Hz), 116.6 (s), 136.5 (d, JPC = 4.9 Hz), 225.2 (s). 31P{1H} NMR 
(C6D6): d –34.0 (s). EI-HRMS Calcd for C17H19MnO3P (M+1): 
357.0452. Found: 357.0440. 
[h5-3,4-(Butan-1,4-diyl)-2,5-
diprenylphospholyl]manganese(I) Tricarbonyl (7c). Yellow oil. 
Yield: 730 mg (19%) from BrMn(CO)5 (2.54 g, 9.24 mmol). 1H 
NMR (C6D6): d 1.27-1.32 (m, 2H), 1.50 (s, 6H), 1.59 (s, 6H), 
1.62-1.67 (m, 2H), 1.98 -2.05 (m, 2H), 2.31-2.25 (m, 2H), 2.64 (m, 
4H), 5.20 (t, J = 6.8 Hz, 2H). 13C{1H} NMR (C6D6): d 17.9 (s), 
22.5 (s), 24.4 (s), 25.6 (s), 27.5 (d, JPC = 17.4 Hz), 113.2 (d, JPC = 
5.5 Hz), 113.8 (d, JPC = 49.7 Hz), 123.0 (d, JPC = 5.3 Hz), 133.5 (s), 
225.6 (s). 31P{1H} NMR (C6D6): d –25.6 (s). EI-HRMS Calcd for 
C21H27MnO3P (M+1): 413.1078. Found: 413.1084. 
3,4-(Butane-1,4-diyl)-1-phenylphosphole (8d). This com-
pound was prepared by the method reported by Mathey, et al.24 A 
mixture of dichlorophenylphosphine (7.56 g, 42.2 mmol) and 1,2-
dimethylenecyclohexane (ca. 80% purity, 9.14 g, ca. 67.7 mmol) 
was place in a flask under nitrogen, and kept stirred for 10 days at 
room temperature to give a white solid. Remaining 1,2-
dimethylenecyclohexane was removed under vacuum, and the 
remaining solid was suspended in a mixture of hexane (30 mL) and 
dichloromethane (15 mL). To this was added 2-methylpyridine 
(8.76 mL, 88.7 mmol) in dichloromethane (15 mL) dropwise, and 
the mixture was stirred for 12 h. The solution was hydrolyzed with 
3N HCl (ca. 20 mL). The organic layer was separated, washed with 
water and brine, and dried over MgSO4. The crude compound was 
purified by silica gel chromatography (hexane/benzene = 1/1) 
under nitrogen to give the title compound as a colorless semi-solid. 
Yield: 4.75 g (53%). 1H NMR (CDCl3): d 1.85 (br, 4H), 2.82 (br, 
4H), 6.62 (m, J = 38.6 Hz, 2H), 7.38-7.41 (m, 3H), 7.48-7.53 (m, 
2H). 13C{1H} NMR (CDCl3): d 23.7 (s), 29.0 (d, JPC = 3.8 Hz), 
127.6 (s), 128.3 (d, JPC = 7.7 Hz), 128.6 (s), 132.2 (d, JPC = 12.0 
Hz), 133.1 (d, JPC = 18.2 Hz), 149.2 (d, JPC = 8.2 Hz). 31P{1H} 
NMR (CDCl3): d 1.8. Anal. Calcd for C14H15P: C, 78.49; H, 7.06. 
Found: C, 78.68; H, 7.06. EI-HRMS Calcd for C14H15P: 214.0911. 
Found: 214.0906. 
Preparation of (h5-Phospholyl)Mn(I)(CO)3 Derivatives 
(7d,e). A typical procedure is given for the synthesis of 7d. A mix-
ture of 8d (3.70 g, 17.3 mg) and lithium wire (1.20 g, 173 mmol) in 
THF (25 mL) was stirred at room temperature for 12 h. Remaining 
excess lithium metal was removed by filtration, then AlCl3 (768 mg, 
5.76 mmol) was added to the filtrate at 0 °C. After stirring the solu-
tion at room temperature for 1 h, methallyl chloride (3.15 g, 34.7 
mmol) was added at 0 °C. All the volatiles were removed under 
reduced pressure, and the residue was dissolved in benzene, which 
was then passed through a pad of silica gel to give crude 9d (2.10 g, 
10.9 mmol; 31P NMR in benzene: d –4.3). A mixture of crude 9d 
(2.10 g) and tBuOK (1.47 g, 13.1 mmol) in THF (20 mL) was 
heated in a sealed tube for 3 h at 140 °C. Resulting phospholide 
10d (31P NMR in THF: d 77.3) was then treated with methallyl 
chloride (3.03 g, 33.5 mmol). The reaction mixture was roughly 
purified by short silica gel column eluting with benzene to give 
crude 11d (2.01 g, 8.16 mmol; 31P NMR in benzene: d –1.8), which 
was then treated with tBuOK (1.10 g, 9.80 mmol) in THF (20 mL) 
in a sealed tube for 3 h at 140 °C. The THF solution of phospholide 
12d thus obtained (31P NMR in THF: d 82.6) was reacted with 
BrMn(CO)5 (1.92 g, 6.98 mmol) at room temperature for 12 h. 
The mixture was evaporated to dryness under reduced pressure, 
then the residue was dissolved in xylenes (15 mL). The mixture was 
heated to 120 °C and stirred for 12 h. After cooling to room tem-
perature, the mixture was filtered through a pad of Celite, and the 
filtrate was evaporated to dryness under reduced pressure. The 
residue was chromatographed on silica gel (hexane/benzene = 
10/1) under nitrogen to give 7d as a yellow solid. The reaction 
conditions were not optimized. The 31P NMR data for the synthetic 
intermediates to 7e: 9e, d –7.4 (benzene); 10e, d 72.4 (THF); 11e, 
d –14.7 (benzene); 12e, d 79.8 (THF). The characterization data 
for 7d,e are given below. 
[h5-3,4-(Butan-1,4-diyl)-2,5-di(2-
methylpropenyl)phospholyl]manganese(I) Tricarbonyl (7d). 
Yellow oil. Yield: 1.36 g (51%) from BrMn(CO)5 (1.92 g, 6.98 
mmol). 1H NMR (C6D6): d 1.27-1.33 (m, 2H), 1.59 (s, 6H), 1.65-
1.72 (m, 2H), 1.86 (s, 6H), 2.06-2.13 (m, 2H), 2.33-2.41 (m, 2H), 
5.66 (br d, J = 12.0 Hz, 2H). 13C{1H} NMR (C6D6): d 20.8 (d, JPC = 
17.6 Hz), 22.6 (s), 25.1 (s), 27.1 (s), 109.4 (d, JPC = 65.0 Hz), 
111.9 (d, JPC = 5.5 Hz), 118.5 (d, JPC = 11.5 Hz), 138.7 (s), 225.5 
(s). 31P{1H} NMR (C6D6): d –27.2. Anal. Calcd for C19H22MnO3P: 
C, 59.38; H, 5.77. Found: C, 59.38; H, 5.71. EI-HRMS Calcd for 
C19H22MnO3P: 384.0687. Found: 384.0676. 
[h5-3,4-Dimethyl-2,5-di(2-
methylpropenyl)phospholyl]manganese(I) Tricarbonyl (7e). 
Yellow oil. Yield: 1.49 g (41%) from BrMn(CO)5 (2.80 g, 10.2 
mmol). 1H NMR (C6D6): d 1.57 (s, 6H), 1.76 (s, 6H), 1.78 (s, 6H), 
5.65 (br d, J = 10.3 Hz, 2H). 13C{1H} NMR (C6D6): d 13.2 (s), 
20.5 (d, JPC = 15.2 Hz), 26.8 (s), 108.8 (d, JPC = 5.5 Hz), 113.4 (d, 
JPC = 63.2 Hz), 118.8 (d, JPC = 12.8 Hz), 139.5 (s), 225.2 (s). 
31P{1H} NMR (C6D6): d –33.0. Anal. Calcd for C17H20MnO3P: C, 
56.94; H, 5.63. Found: C, 56.56; H, 5.57. EI-HRMS Calcd for 
C17H20MnO3P: 358.0531. Found: 358.0527. 
Preparation of (h5-Phospholyl)Mn(I)(CO)2(phosphine) 
Derivatives (1a-e). A benzene solution (10 mL) of 7 (0.50 mmol) 
and allyldiphenylphosphine (0.50 mmol) was irradiated by mercu-
ry lamp (300 W, Eikosha Inc.) for 15 h at room temperature. The 
resulting solution was filtered and the filtrate was evaporated to 
dryness under reduced pressure. The residue was purified by silica 
gel chromatography (hexane/EtOAc = 10/1) under nitrogen to 
give 1 as a yellow solid. The characterization data for 1a-e are given 
below. 
 [h5-3,4-(Butan-1,4-diyl)-2,5-dimethallylphospholyl](allyl-
diphenylphosphine)manganese(I) Dicarbonyl (1a). Yellow 
solid. Mp: 112.0-112.3 °C. Yield: 1.22 g (68%) from 7a (1.18 g, 
3.07 mmol). 1H NMR (CDCl3): d 1.57 (s, 6H), 1.57-1.62 (m, 2H), 
1.67-1.74 (m, 2H), 1.89-1.98 (m, 2H), 2.32-2.57 (m, 6H), 3.31 (t, J 
= 8.4 Hz, 2H), 4.47 (br, 2H), 4.63 (br, 2H), 4.77 (br d, J = 16.9 Hz, 
1H), 4.90 (br d, J = 10.1 Hz, 1H), 5.46-5.58 (m, 1H), 7.33-7.40 (m, 
6H), 7.56-7.60 (m, 4H). 13C{1H} NMR (CDCl3): d 22.5 (d, JPC = 
2.4 Hz), 22.7 (s), 24.0 (s), 35.1 (d, JPC = 18.5 Hz), 42.6 (dd, JPC = 
26.8 and 4.7 Hz), 104.9 (d, JPC = 57.1 Hz), 110.6 (s), 111.0 (dd, JPC 
= 5.3 and 2.3 Hz), 119.1 (d, JPC = 10.6 Hz), 127.9 (d, JPC = 8.9 Hz), 
129.3 (d, JPC = 2.1 Hz), 130.7 (d, JPC = 5.3 Hz), 132.7 (dd, JPC = 8.9 
and 1.8 Hz), 138.7 (d, JPC = 39.2 Hz), 145.5 (s), 231.6 (d, JPC = 26.2 
Hz). 31P{1H} NMR (CDCl3): d –11.6 (s), 84.2 (br). Anal. Calcd 
for C33H37MnO2P2: C, 68.04; H, 6.40. Found: C, 68.23; H, 6.49. EI-
HRMS Calcd for C33H37MnO2P2: 582.1649. Found: 582.1641. 
[h5-3,4-(Butan-1,4-diyl)-2,5-diallylphospholyl](allyl-
diphenylphosphine)manganese(I) Dicarbonyl (1b). Yellow 
solid. Mp: 107.3-107.5 °C. Yield: 740 mg (63%) from 7b (755 mg, 
2.12 mmol). 1H NMR (CDCl3): d 1.66-1.84 (m, 4H), 1.89-2.01 (m, 
2H), 2.31-2.42 (m, 2H), 2.45-2.60 (m, 4H), 3.31 (t, J = 8.2 Hz, 
2H), 4.71-4.93 (m, 6H), 5.44-5.64 (m, 3H), 7.32-7.41 (m, 6H), 
7.53-7.61 (m, 4H). 13C{1H} NMR (CDCl3): d 22.6 (s), 24.1 (s), 
31.5 (d, JPC = 18.8 Hz), 42.6 (dd, JPC = 26.6 and 4.3 Hz), 105.8 (d, 
JPC = 57.1 Hz), 110.4 (d, JPC = 3.5 Hz), 114.8 (s), 119.0 (d, JPC = 
10.4 Hz), 127.8 (d, JPC = 8.9 Hz), 129.2 (s), 130.6 (d, JPC = 5.1 Hz), 
132.6 (d, JPC = 8.6 Hz), 138.2 (d, JPC = 2.6 Hz), 138.6 (d, JPC = 38.8 
Hz), 231.5 (d, JPC = 26.3 Hz). 31P{1H} NMR (CDCl3): d –16.5 (s), 
83.8 (s). EI-HRMS Calcd for C31H34MnO2P2 (M+1): 555.1415. 
Found: 555.1409. 
[h5-3,4-(Butan-1,4-diyl)-2,5-diprenylphospholyl](allyl-
diphenylphosphine)manganese(I) Dicarbonyl (1c). Yellow 
solid. Mp: 119.1-119.4 °C. Yield: 650 mg (61%) from 7c (720 mg, 
1.75 mmol). 1H NMR (CDCl3): d 1.47 (s, 6H), 1.60 (s, 6H), 1.70-
1.81 (m, 4H), 1.93-2.01 (m, 2H), 2.32-2.46 (m, 4H), 2.53-2.60 (m, 
2H), 3.32 (t, J = 8.4 Hz, 2H), 4.75 (br d, J = 16.8 Hz, 1H), 4.87-
4.93 (m, 3H), 5.51-5.59 (m, 1H), 7.34-7.40 (m, 6H), 7.56-7.61 (m, 
4H). 13C{1H} NMR (CDCl3): d 17.9 (s), 22.6 (s), 24.2 (s), 25.6 
(s), 26.2 (d, JPC = 18.6 Hz), 42.9 (dd, JPC = 26.4 and 4.4 Hz), 108.1 
(d, JPC = 56.9 Hz), 110.1 (d, JPC = 3.3 Hz), 118.8 (d, JPC = 10.3 Hz), 
124.3 (d, JPC = 3.5 Hz), 127.8 (d, JPC = 8.9 Hz), 129.2 (d, JPC = 1.3 
Hz), 130.9 (d, JPC = 5.3 Hz), 131.3 (s), 132.7 (d, JPC = 8.8 Hz), 
138.7 (d, JPC = 38.4 Hz), 231.8 (d, JPC = 26.0 Hz). 31P{1H} NMR 
(CDCl3): d –17.8 (s), 83.8 (s). EI-HRMS Calcd for C35H42MnO2P2 
(M+1): 611.2041. Found: 611.2013. 
[h5-3,4-(Butan-1,4-diyl)-2,5-di(2-methylpropenyl)phos-
pholyl](allyldiphenylphosphine)manganese(I) Dicarbonyl 
(1d). Yellow solid. Mp: 164.3-164.7 °C. Yield: 1.58 g (77%) from 
7d (1.35 g, 3.51 mmol). 1H NMR (CDCl3): d 1.60 (s, 12H), 1.75-
1.78 (m, 2H), 1.98-2.04 (m, 2H), 2.34-2.41 (m, 2H), 2.68-2.75 (m, 
2H), 3.22 (t, J = 8.4 Hz, 2H), 4.77 (dd, J = 17.2 and 2.4 Hz, 1H), 
4.87 (d, J = 9.6 Hz, 1H), 5.35 (d, J = 12.4 Hz, 2H), 5.47-5.55 (m, 
1H), 7.26-7.34 (m, 6H), 7.43-7.47 (m, 4H). 13C{1H} NMR 
(CDCl3): d 20.0 (d, JPC = 20.0 Hz), 23.0 (s), 25.1 (s), 27.3 (s), 41.8 
(dd, JPC = 26.5 and 2.7 Hz), 103.5 (d, JPC = 60.6 Hz), 108.9 (d, JPC = 
4.5 Hz), 119.0 (d, JPC = 10.2 Hz), 119.4 (d, JPC = 10.9 Hz), 127.6 (d, 
JPC = 9.1 Hz), 128.9 (s), 131.1 (d, JPC = 5.2 Hz), 132.6 (d, JPC = 9.2 
Hz), 135.8 (s), 138.2 (d, JPC = 39.5 Hz), 231.7 (d, JPC = 25.3 Hz). 
31P{1H} NMR (CDCl3): d –12.6 (s), 83.5 (s). Anal. Calcd for 
C33H37MnO2P2: C, 68.04; H, 6.40. Found: C, 67.86; H, 6.61. EI-
HRMS Calcd for C33H37MnO2P2: 582.1649. Found: 582.1649. 
[h5-3,4-Dimethyl-2,5-di(2-methylpropenyl)phospholyl]-
(allyldiphenylphosphine)manganese(I) Dicarbonyl (1e). Yel-
low solid. Mp: 135.3-135.6 °C. Yield: 1.67 g (73%) from 7e (1.48 g, 
4.13 mmol). 1H NMR (CDCl3): d 1.60 (s, 6H), 1.61 (s, 6H), 2.10 
(s, 6H), 3.21 (dd, J = 9.0 and 7.9 Hz, 2H), 4.75-4.81 (m, 1H), 4.86-
4.90 (m, 1H), 5.32 (br d, 11.6 Hz, 2H), 5.47-5.59 (m, 1H), 7.26-
7.35 (m, 6H), 7.43-7.49 (m, 4H). 13C{1H} NMR (CDCl3): d 13.8 
(s), 19.9 (d, JPC = 15.2 Hz), 27.3 (s), 41.7 (d, JPC = 26.2 Hz), 105.8 
(d, JPC = 59.5 Hz), 106.7 (d, JPC = 4.8 Hz), 119.1 (d, JPC = 10.3 Hz), 
119.8 (d, JPC = 12.2 Hz), 127.7 (d, JPC = 9.1 Hz), 129.1 (s), 131.1 (d, 
JPC = 5.5 Hz), 132.7 (d, JPC = 7.9 Hz), 136.4 (s), 138.1 (d, JPC = 39.4 
Hz), 231.9 (d, JPC = 24.9 Hz). 31P{1H} NMR (CDCl3): d –15.4 (s), 
83.0 (s). Anal. Calcd for C31H35MnO2P2: C, 66.91; H, 6.34. Found: 
C, 66.86; H, 6.63. EI-HRMS Calcd for C31H35MnO2P2: 556.1493. 
Found: 556.1477. 
General Procedure for Molybdenum-Catalyzed ARCM 
Desymmetrization of 1. In a glovebox, Mo(=NC6H3-2,6-
iPr2)(=CHCMe2Ph)(NC4H4)2 (1.9 mg, 3.5 µmol) and an appro-
priate chiral ligand L (3.6 µmol) were dissolved in dry benzene (5 
mL) in a test tube with a Teflon-sealed screw cap. After stirring the 
mixture for 15 min at room temperature, benzene (2 mL) and 
phosphacymantrene substrate 1 (35 µmol) were added. The test 
tube was sealed tightly and taken out of the glovebox. The test tube 
was immersed in an oil bath maintained at 23 °C and the mixture 
was stirred for 12 h. After quenching the reaction by addition of 
acetone (ca. 100 µL), the solvent was removed under reduced 
pressure. The residue was purified by silica gel chromatography 
(hexane/Et2O = 5/1) to give the ARCM product as yellow-orange 
crystalline powder. The characterization data of the ARCM prod-
ucts and the condition for the chiral HPLC analysis are given below. 
[h5-3,4-(Butan-1,4-diyl)-2-(4-diphenylphosphino-2-
methylbut-2-enyl)-5-methallylphospholyl-P]manganese(I) 
Dicarbonyl (2a). Yellow solid. Mp: 197.6-197.9 °C (racemate). 
Yield: 19.1 mg (from 20.0 mg of 1a, >99%; Table 1, entry 2). 1H 
NMR (CDCl3): d 1.65-1.77 (m, 2H), 1.73 (d, J = 6.3 Hz, 3H), 1.83 
(s, 3H), 1.93-2.03 (m, 1H), 2.05-2.14 (m, 1H), 2.39-2.55 (m, 3H), 
2.64-2.78 (m, 2H), 2.89-2.94 (m, 1H), 3.03-3.14 (m, 2H), 3.19-
3.33 (m, 2H), 4.78 (br, 1H), 4.82 (br, 1H), 5.05-5.10 (br m, 1H), 
7.15-7.29 (m, 5H), 7.40-7.43 (m, 3H), 7.95-8.00 (m, 2H). 13C{1H} 
NMR (CDCl3): d 22.5 (s), 22.6 (s), 22.9 (d, JPC = 3.2 Hz), 24.6 (s), 
25.0 (s), 25.9 (dd, JPC = 6.2 and 3.2 Hz), 31.2 (d, JPC = 19.5 Hz), 
31.6 (d, JPC = 17.1 Hz), 37.4 (d, JPC = 18.9 Hz), 97.2 (d, JPC = 53.5 
Hz), 105.8 (d, JPC = 5.9 Hz), 110.4 (d, JPC = 60.0 Hz), 111.6 (s), 
113.0 (dd, JPC = 5.0 and 2.1 Hz), 118.4 (d, JPC = 5.0 Hz), 127.7 (d, 
JPC = 9.4 Hz), 127.8 (d, JPC = 8.9 Hz), 128.3 (d, JPC = 2.0 Hz), 
129.66 (d, JPC = 7.9 Hz), 129.67 (d, JPC = 2.4 Hz), 134.2 (dd, JPC = 
10.4 and 4.8 Hz), 138.4 (d, JPC = 39.5 Hz), 140.0 (dd, JPC = 9.8 and 
5.3 Hz), 142.9 (d, JPC = 40.9 Hz), 145.1 (s), 230.4 (d, JPC = 24.5 
Hz), 230.8 (d, JPC = 23.3 Hz). 31P{1H} NMR (CDCl3): d –31.3 (d, 
JPP = 5.7 Hz), 77.9 (br). Anal. Calcd for C31H33MnO2P2: C, 67.15; 
H, 6.00. Found: C, 67.19; H, 5.96. EI-HRMS Calcd for 
C31H33MnO2P2: 554.1336. Found: 554.1326. [a]22D = –27.9 (c 1.62, 
CHCl3 for the sample of 91% ee). Chiral HPLC Analysis Condi-
tions: Chiralcel OD-H; eluent, hexane/iPrOH = 500/1; flow rate, 
0.5 mL/min; t1 = 16.8 min, t2 = 19.0 min. 
 [h5-3,4-(Butan-1,4-diyl)-2-(4-diphenylphosphino-2-
butenyl)-5-allylphospholyl-P]manganese(I) Dicarbonyl (2b). 
Yellow solid. Mp: 200.0-200.6 °C (racemate). Yield: 12.1 mg (from 
16.6 mg of 1b, 77%; Table 1, entry 5). 1H NMR (CDCl3): d 1.65-
1.82 (m, 2H), 1.92-2.04 (m, 1H), 2.04-2.16 (m, 1H), 2.40-2.57 (m, 
3H), 2.68-2.86 (m, 2H), 2.90-3.23 (m, 4H), 3.38-3.50 (m, 1H), 
5.08-5.20 (m, 2H), 5.43-5.53 (m, 1H), 5.81-6.00 (m, 2H), 7.19-
7.31 (m, 5H), 7.39-7.46 (m, 3H), 7.96-8.05 (m, 2H). 13C{1H} 
NMR (CDCl3): d 22.3 (s), 22.6 (s), 24.5 (s), 25.0 (s), 26.0 (d, JPC 
= 19.1 Hz), 28.0 (d, JPC = 15.9 Hz), 30.7 (d, JPC = 17.9 Hz), 33.6 (d, 
JPC = 17.8 Hz), 99.8 (d, JPC = 47.7 Hz), 104.2 (d, JPC = 5.9 Hz), 
112.5 (d, JPC = 59.6 Hz), 113.6 (d, JPC = 3.3 Hz), 116.1 (s), 125.1 (d, 
JPC = 4.4 Hz), 127.6 (s), 127.7 (s), 127.8 (s), 127.9 (s), 128.5 (s), 
129.8 (d, JPC = 8.7 Hz), 131.4 (dd, JPC = 8.9 and 6.4 Hz), 133.9 (dd, 
JPC = 10.2 and 4.4 Hz), 137.3 (d, JPC = 5.4 Hz), 139.2 (d, JPC = 39.0 
Hz), 133.1 (s), 142.2 (d, JPC = 40.9 Hz), 230.4 (d, JPC = 20.2 Hz), 
230.6 (d, JPC = 20.2 Hz). 31P{1H} NMR (CDCl3): d –32.9 (s), 77.4 
(s). EI-HRMS Calcd for C29H30MnO2P2 (M+1): 527.1102. Found: 
527.1081. Chiral HPLC Analysis Conditions: Chiralcel OD-H; 
eluent, hexane/iPrOH = 500/1; flow rate, 0.5 mL/min; t1 = 24.9 
min, t2 = 33.7 min. 
[h5-3,4-(Butan-1,4-diyl)-2-(4-diphenylphosphino-2-
methylbut-2-enyl)-5-prenylphospholyl-P]manganese(I) Di-
carbonyl (2c). Yellow solid. Mp: 142.5-142.7 °C (racemate). 
Yield: 16.6 mg (from 18.3 mg of 1c, >99%; Table 1, entry 6). 1H 
NMR (CDCl3): d 1.66-1.79 (m, 2H), 1.72 (s, 3H), 1.81 (s, 3H), 
1.95-2.02 (m, 1H), 2.07-2.15 (m, 1H), 2.40-2.49 (m, 2H), 2.52-
2.59 (m, 1H), 2.70-2.84 (m, 2H), 2.90-2.98 (m, 2H), 3.03-3.11 (m, 
1H), 3.13-3.22 (m, 1H), 3.38-3.46 (m, 1H), 5.36 (t, J = 7.6 Hz, 
1H), 5.44-5.52 (m, 1H), 5.82-5.90 (m, 1H), 7.21-7.30 (m, 5H), 
7.39-7.43 (m, 3H), 7.99-8.05 (m, 2H). 13C{1H} NMR (CDCl3): d 
18.1 (s), 22.3 (s), 22.6 (s), 24.6 (s), 25.1 (s), 25.9 (s), 26.0 (d, JPC = 
19.8 Hz), 28.0 (d, JPC = 15.9 Hz), 30.8 (d, JPC = 17.9 Hz), 99.4 (d, 
JPC = 51.7 Hz), 103.8 (d, JPC = 5.9 Hz), 113.8 (d, JPC = 3.3 Hz), 
115.4 (d, JPC = 58.7 Hz), 123.1 (d, JPC = 6.5 Hz), 125.0 (d, JPC = 4.4 
Hz), 127.8 (d, JPC = 13.9 Hz), 127.9 (d, JPC = 13.2 Hz), 128.5 (s), 
129.7 (s), 129.8 (d, JPC = 8.3 Hz), 131.4 (dd, JPC = 10.0 and 6.5 Hz), 
133.1 (s), 133.85 (d, JPC = 10.0 Hz), 133.94 (d, JPC = 10.0 Hz), 
139.4 (d, JPC = 38.7 Hz), 142.3 (d, JPC = 41.0 Hz), 230.51 (d, JPC = 
24.0 Hz), 230.55 (d, JPC = 24.0 Hz). 31P{1H} NMR (CDCl3): d –
33.1 (s), 77.5 (s). [a]24D = –4.90 (c 3.10, EtOAc for the sample of 
89% ee). Anal. Calcd for C31H33MnO2P2: C, 67.15; H, 6.00. Found: 
C, 67.19; H, 5.96. EI-HRMS Calcd for C31H34MnO2P2 (M+1): 
555.1415. Found: 555.1409. Chiral HPLC Analysis Conditions: 
Chiralcel OD-H; eluent, hexane/iPrOH = 2000/1; flow rate, 0.5 
mL/min; t1 = 45.9 min, t2 = 50.7 min. 
[h5-3,4-(Butan-1,4-diyl)-2-(3-diphenylphosphino-1-
propenyl)-5-(2-methylpropenyl)phospholyl-P]manganese(I) 
Dicarbonyl (2d). Yellow solid. Mp: 129.3-129.5 °C (racemate). 
Yield: 15.9 mg (from 17.5 mg of 1d, >99%; Table 1, entry 8). 1H 
NMR (CDCl3): d 1.72-1.81 (m, 2H), 1.83 (s, 3H), 1.89 (s, 3H), 
1.99-2.11 (m, 2H), 2.30-2.38 (m, 1H), 2.45-2.60 (m, 2H), 2.67-
2.75 (m, 1H), 2.80-2.88 (m, 1H), 2.92-3.01 (m, 1H), 5.68-5.77 (m, 
1H), 5.82 (d, J = 11.6 Hz, 1H), 6.29-6.33 (m, 1H), 7.27-7.31 (m, 
4H), 7.34-7.40 (m, 4H), 7.67-7.72 (m, 2H). 13C{1H} NMR 
(CDCl3): d 20.6 (d, JPC = 15.8 Hz), 22.67 (s), 22.74 (s), 25.3 (s), 
25.5 (s), 27.2 (s), 30.4 (d, JPC = 20.4 Hz), 101.6 (d, JPC = 60.8 Hz), 
106.0 (s), 109.6 (s), 110.9 (d, JPC = 61.1 Hz), 119.8 (d, JPC = 11.2 
Hz), 125.6 (s), 127.1 (dd, JPC = 13.8 and 13.5 Hz), 128.1 (d, JPC = 
8.5 Hz), 128.4 (s), 129.3 (s), 129.5 (s), 131.3 (d, JPC = 8.9 Hz), 
132.4 (d, JPC = 8.4 Hz), 137.0 (s), 138.4 (d, JPC = 38.1 Hz), 139.3 (d, 
JPC = 41.5 Hz), 229.7 (d, JPC = 19.7 Hz), 230.2 (d, JPC = 24.2 Hz). 
31P{1H} NMR (CDCl3): d –44.4 (d, JPP = 12.5 Hz), 109.4 (br). EI-
HRMS Calcd for C29H29MnO2P2: 526.1023. Found: 526.1031. 
[a]24D = –91.3 (c 2.60, EtOAc for the sample of 97% ee). Chiral 
HPLC Analysis Conditions: Chiralpak IA; eluent, hexane/iPrOH = 
2000/1; flow rate, 0.5 mL/min; t1 = 25.5 min, t2 = 32.5 min. 
[h5-3,4-Dimethyl-2-(3-diphenylphosphino-1-propenyl)-5-
(2-methylpropenyl)phospholyl-P]manganese(I) Dicarbonyl 
(2e). Yellow solid. Mp: 115.8-116.0 °C (racemate). Yield: 17.6 mg 
(from 20.0 mg of 1e, >99%; Table 1, entry 10). 1H NMR (CDCl3): 
d 1.81 (s, 3H), 1.85 (s, 3H), 2.01 (s, 3H), 2.12 (s, 3H), 2.73-2.81 
(m, 1H), 2.88-2.95 (m, 1H), 5.68-5.77 (m, 1H), 5.80 (br d, J = 8.8 
Hz, 1H), 6.29-6.32 (m, 1H), 7.31-7.40 (m, 8H), 7.67-7.72 (m, 2H). 
13C{1H} NMR (CDCl3): d 13.6 (s), 13.9 (s), 20.3 (d, JPC = 12.3 
Hz), 26.8 (s), 30.1 (dd, JPC = 20.9 and 3.7 Hz), 103.9 (d, JPC = 6.8 
Hz), 105.2 (dd, JPC = 59.0 and 3.0 Hz), 106.1 (d, JPC = 2.5 Hz), 
112.3 (d, JPC = 59.7 Hz), 120.2 (d, JPC = 12.9 Hz), 126.1 (d, JPC = 
3.7 Hz), 127.2 (dd, JPC = 28.9 and 16.0 Hz), 128.16 (d, JPC = 8.6 
Hz), 128.20 (d, JPC = 9.2 Hz), 129.4 (d, JPC = 1.2 Hz), 129.5 (d, JPC 
= 1.9 Hz), 131.6 (d, JPC = 9.9 Hz), 132.3 (dd, JPC = 9.8 and 1.9 Hz), 
137.7 (s), 138.3 (d, JPC = 38.8 Hz), 139.0 (d, JPC = 40.7 Hz), 229.7 
(d, JPC = 19.1 Hz), 229.9 (d, JPC = 19.1 Hz). 31P{1H} NMR 
(CDCl3): d –47.7 (d, JPP = 10.0 Hz), 106.0 (br). Anal. Calcd for 
C27H27MnO2P2: C, 64.81; H, 5.44. Found: C, 64.86; H, 5.68. 
HRMS Calcd for C27H27MnO2P2: 500.0867. Found: 500.0859. 
[a]22D = –180.5 (c 1.02, CHCl3 for the sample of 99% ee). Chiral 
HPLC Analysis Conditions: Chiralpak IA; eluent, hexane/iPrOH = 
1000/1; flow rate, 0.5 mL/min; t1 = 17.9 min, t2 = 21.1 min. 
Palladium-Catalyzed Asymmetric Allylic Alkylation of rac-
1,3-Diphenyl-2-propenyl Acetate. To a mixture of [PdCl(p-
C3H5)]2 (2.1 mg, 5.7 µmol), (R)-(–)-2d (6.0 mg, 11.4 µmol), 
KOAc (1.0 mg, 10 µmol), and rac-1,3-diphenyl-2-propenylacetate 
(40.0 mg, 159 µmol) in CH2Cl2 (1 mL) was added N,O-
bis(trimethylsilyl)acetamide (103 mg, 506 µmol), and dimethyl 
malonate (67.0 mg, 507 µmol) at 0 ºC under nitrogen. The flask 
was immersed in a bath maintained at 0 ºC, and the solution was 
stirred for 7 days. The reaction mixture was passed through a short 
pad of silica gel and washed with cold CH2Cl2. After evaporation of 
the filtrate, the residue was purified by preparative TLC on silica gel 
(eluent: hexane/EtOAc = 5/1) to give the alkylated product of (S)-
configuration in pure form. Yield: 28.1 mg (86.6 µmol, 54%). The 
enantiopurity and the absolute configuration of the product were 
determined as reported.25 
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